AU2004303740A1 - Nicotinic acetylcholine receptor ligands - Google Patents
Nicotinic acetylcholine receptor ligands Download PDFInfo
- Publication number
- AU2004303740A1 AU2004303740A1 AU2004303740A AU2004303740A AU2004303740A1 AU 2004303740 A1 AU2004303740 A1 AU 2004303740A1 AU 2004303740 A AU2004303740 A AU 2004303740A AU 2004303740 A AU2004303740 A AU 2004303740A AU 2004303740 A1 AU2004303740 A1 AU 2004303740A1
- Authority
- AU
- Australia
- Prior art keywords
- azabicyclo
- oct
- disease
- atoms
- sulfur
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53164803P | 2003-12-22 | 2003-12-22 | |
| US60/531,648 | 2003-12-22 | ||
| PCT/SE2004/001943 WO2005061495A1 (en) | 2003-12-22 | 2004-12-20 | Nicotinic acetylcholine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2004303740A1 true AU2004303740A1 (en) | 2005-07-07 |
Family
ID=34710243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004303740A Abandoned AU2004303740A1 (en) | 2003-12-22 | 2004-12-20 | Nicotinic acetylcholine receptor ligands |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070191422A1 (enExample) |
| EP (1) | EP1699787A1 (enExample) |
| JP (1) | JP2007515481A (enExample) |
| KR (1) | KR20060123365A (enExample) |
| CN (1) | CN1914200A (enExample) |
| AU (1) | AU2004303740A1 (enExample) |
| BR (1) | BRPI0417933A (enExample) |
| CA (1) | CA2550847A1 (enExample) |
| IL (1) | IL176073A0 (enExample) |
| MX (1) | MXPA06007024A (enExample) |
| NO (1) | NO20063331L (enExample) |
| SG (1) | SG149051A1 (enExample) |
| WO (1) | WO2005061495A1 (enExample) |
| ZA (1) | ZA200605024B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| PT1791811E (pt) * | 2004-09-21 | 2010-02-23 | Astellas Pharma Inc | ¿derivados de aminoálcool |
| EP2593447B1 (de) | 2010-07-15 | 2016-08-17 | Bayer Intellectual Property GmbH | 3-pyridyl-heteroarylcarboxamidverbindungen als schädlingsbekämpfungsmittel |
| KR101928505B1 (ko) * | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| WO2002015662A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| WO2002017358A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| JP2004506734A (ja) * | 2000-08-21 | 2004-03-04 | ファルマシア・アンド・アップジョン・カンパニー | 疾患治療用のキヌクリド置換ヘテロアリール部分 |
| DE10156719A1 (de) * | 2001-11-19 | 2003-05-28 | Bayer Ag | Heteroarylcarbonsäureamide |
-
2004
- 2004-12-20 EP EP04809116A patent/EP1699787A1/en not_active Withdrawn
- 2004-12-20 CA CA002550847A patent/CA2550847A1/en not_active Abandoned
- 2004-12-20 KR KR1020067012363A patent/KR20060123365A/ko not_active Withdrawn
- 2004-12-20 SG SG200809494-8A patent/SG149051A1/en unknown
- 2004-12-20 WO PCT/SE2004/001943 patent/WO2005061495A1/en not_active Ceased
- 2004-12-20 BR BRPI0417933-1A patent/BRPI0417933A/pt not_active IP Right Cessation
- 2004-12-20 MX MXPA06007024A patent/MXPA06007024A/es unknown
- 2004-12-20 JP JP2006546911A patent/JP2007515481A/ja not_active Abandoned
- 2004-12-20 AU AU2004303740A patent/AU2004303740A1/en not_active Abandoned
- 2004-12-20 US US10/583,581 patent/US20070191422A1/en not_active Abandoned
- 2004-12-20 CN CNA2004800412792A patent/CN1914200A/zh active Pending
-
2006
- 2006-05-31 IL IL176073A patent/IL176073A0/en unknown
- 2006-06-19 ZA ZA200605024A patent/ZA200605024B/en unknown
- 2006-07-18 NO NO20063331A patent/NO20063331L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06007024A (es) | 2006-08-31 |
| EP1699787A1 (en) | 2006-09-13 |
| IL176073A0 (en) | 2006-10-05 |
| CA2550847A1 (en) | 2005-07-07 |
| WO2005061495A1 (en) | 2005-07-07 |
| JP2007515481A (ja) | 2007-06-14 |
| BRPI0417933A (pt) | 2007-04-17 |
| SG149051A1 (en) | 2009-01-29 |
| CN1914200A (zh) | 2007-02-14 |
| US20070191422A1 (en) | 2007-08-16 |
| ZA200605024B (en) | 2007-04-25 |
| KR20060123365A (ko) | 2006-12-01 |
| NO20063331L (no) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2233282C2 (ru) | Аралкиламины фуропиридинов, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества | |
| AU784400B2 (en) | New use and novel N-azabicyclo-amide derivatives | |
| US7566727B2 (en) | 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor | |
| KR20040003021A (ko) | 치료에 유용한 니코틴성 아세틸콜린 수용체에 대한 신규리간드 | |
| ZA200605027B (en) | Nicotinic acetylcholine receptor ligands | |
| US20070191422A1 (en) | Nicotinic acetylcholine receptor ligands | |
| AU2004303737A1 (en) | Nicotinic acetylcholine receptor ligands | |
| US7384954B2 (en) | 4-substituted imidazoles | |
| CN100445285C (zh) | 烟碱性乙酰胆碱受体配体 | |
| AU2004291456A1 (en) | 5-substituted imidazoles | |
| MXPA06011725A (en) | Novel 2-(1-aza-bicyclo [2.2.2]oct-3-yl) -2, 3-dihydroisoindol -l-one/5, 6-dihydro-furo[2, 3-c]pyrrol -4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor | |
| MXPA06005416A (en) | 4-substituted imidazoles | |
| KR20070020445A (ko) | 알파 7 니코틴성 아세틸콜린 수용체를 위한 신규한2-(1-아자-비시클로[2.2.2]옥트-3-일)-2,3-디히드로이소인돌-1-온/5,6-디히드로-푸로[2,3-ｃ]피롤-4-온 유도체리간드 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |